Clinical Trial Update: Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the safety and immunogenicity of the Measles-Mumps-Rubella vaccine delivered by a needle-free DSJI device compared to needle-syringe i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella

Drugs mentioned

• Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Immune Response to MMR Vaccine | Phase 4 | Status: COMPLETED